Ontario startup High Q aims to speed up drug discovery for diseases such as Alzheimer’s through quantum sensors

High Q Technologies, based in Waterloo, Ontario, is pioneering advanced quantum sensor technology to map the intricate, dynamic structures of proteins with unmatched precision. This innovation could drastically speed up the drug discovery process, especially for complex diseases like Alzheimer’s, where understanding protein behavior is crucial. The potential global impact is significant, as this technology could revolutionize how we approach treatments for a range of diseases by providing detailed insights into molecular interactions. With a promising market ahead, High Q’s work stands at the forefront of merging quantum technology with biomedical research.